SecBot SecBot
SECBOTREPLAY Home › Report › STRO

STRO · Sutro Biopharma is holding its annual shareholder meeting to elect…

SUTRO BIOPHARMA, INC. · DEFA14A filed Apr 22, 2026 at 16:15 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Apr 22, 2026 at 16:15 ET

Sutro Biopharma is holding its annual shareholder meeting to elect directors, ratify auditors, and approve executive compensation. This is a routine corporate governance filing with no material financial or strategic changes.

  • Sutro Biopharma is holding its annual shareholder meeting on June 5, 2026
  • Shareholders will vote on the election of Class II directors (Jane Chung, Connie Matsui, James Panek)
  • Shareholders will vote to ratify Ernst & Young LLP as the independent auditor
  • Shareholders will vote on a non-binding advisory vote on executive compensation

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access